133 related articles for article (PubMed ID: 32686984)
1. Effects of Rapamycin Combined with Cisplatin on Tumor Necrosis Factor TNF-α in MG-63 Cells.
Han TY; Ma B; Hu B; Xiang LB; Liu XW
Cell Transplant; 2020; 29():963689720926153. PubMed ID: 32686984
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
Robl B; Botter SM; Pellegrini G; Neklyudova O; Fuchs B
J Exp Clin Cancer Res; 2016 Jul; 35(1):113. PubMed ID: 27421768
[TBL] [Abstract][Full Text] [Related]
3. Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
Mizutani Y; Bonavida B
Cancer; 1993 Aug; 72(3):809-18. PubMed ID: 8334635
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effect of liposome-encapsulated cisplatin on rat osteosarcoma and its enhancement by caffeine.
Karita M; Tsuchiya H; Kawahara M; Kasaoka S; Tomita K
Anticancer Res; 2008; 28(3A):1449-57. PubMed ID: 18630498
[TBL] [Abstract][Full Text] [Related]
5. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
[TBL] [Abstract][Full Text] [Related]
7. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
8. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line.
Ziyan W; Yang L
Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the expression of TAM, survivin and the degree of necrosis of the tumor after cisplatin treatment in osteosarcoma.
Chen G
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):490-497. PubMed ID: 28239822
[TBL] [Abstract][Full Text] [Related]
12. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
[TBL] [Abstract][Full Text] [Related]
13. ANXA2 and Rac1 negatively regulates autophagy and osteogenic differentiation in osteosarcoma cells to confer CDDP resistance.
Pan B; Pan Y; Wang S; Bai Y; Hu X; Yang Y; Wu L; Liu J
Biochem Biophys Res Commun; 2023 Oct; 676():198-206. PubMed ID: 37536195
[TBL] [Abstract][Full Text] [Related]
14. Id3-mediated enhancement of cisplatin-induced apoptosis in a sarcoma cell line MG-63.
Koyama T; Suzuki H; Imakiire A; Yanase N; Hata K; Mizuguchi J
Anticancer Res; 2004; 24(3a):1519-24. PubMed ID: 15274318
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin.
Duan L; Aoyagi M; Tamaki M; Nakagawa K; Nagashima G; Nagasaka Y; Ohno K; Yamamoto K; Hirakawa K
J Neurooncol; 2001 Mar; 52(1):23-36. PubMed ID: 11451200
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1.
Chen Y; Zhang K; Li Y; Guo R; Zhang K; Zhong G; He Q
J Cell Mol Med; 2019 Mar; 23(3):2115-2124. PubMed ID: 30609256
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
